Log in to save to my catalogue

Renal cell carcinoma: the population, real world, and cost-of-illness

Renal cell carcinoma: the population, real world, and cost-of-illness

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b7c0b6dfeb9a4ee5ad0ad00faec961ee

Renal cell carcinoma: the population, real world, and cost-of-illness

About this item

Full title

Renal cell carcinoma: the population, real world, and cost-of-illness

Publisher

England: BioMed Central Ltd

Journal title

BMC urology, 2022-12, Vol.22 (1), p.206-8, Article 206

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The RCC treatment landscape has evolved dramatically over the past decade. The purpose of this study is to present a real-world data estimation of RCC's cost-of-illness for this tumour's clinical pathway.
This investigation is a population-based cohort study using real-world data, which considers all RCC incident cases diagnosed in Local Unit 6...

Alternative Titles

Full title

Renal cell carcinoma: the population, real world, and cost-of-illness

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b7c0b6dfeb9a4ee5ad0ad00faec961ee

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b7c0b6dfeb9a4ee5ad0ad00faec961ee

Other Identifiers

ISSN

1471-2490

E-ISSN

1471-2490

DOI

10.1186/s12894-022-01160-y

How to access this item